Cas:960009-55-6 1,2,3,4-tetrahydro-N-(4-methoxyphenyl)-1-Naphthalenamine manufacturer & supplier

Chemical Name:1,2,3,4-tetrahydro-N-(4-methoxyphenyl)-1-Naphthalenamine

CAS.NO:960009-55-6

Synonyms:MFCD12625160;N-(4-Methoxyphenyl)-1,2,3,4-tetrahydro-1-naphthalenamine;1-Naphthalenamine, 1,2,3,4-tetrahydro-N-(4-methoxyphenyl)-

Molecular Formula:C₁₇H₁₉NO

Molecular Weight:253.339

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:419.8±38.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.618

PSA:

Exact Mass:253.146667

LogP:4.13

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like MFCD12625160 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Naphthalenamine, 1,2,3,4-tetrahydro-N-(4-methoxyphenyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Naphthalenamine, 1,2,3,4-tetrahydro-N-(4-methoxyphenyl)- Use and application,N-(4-Methoxyphenyl)-1,2,3,4-tetrahydro-1-naphthalenamine technical grade,usp/ep/jp grade.

Related News: An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. 1,2,3,4-tetrahydro-N-(4-methoxyphenyl)-1-Naphthalenamine manufacturer U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year. 1,2,3,4-tetrahydro-N-(4-methoxyphenyl)-1-Naphthalenamine supplier However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 1,2,3,4-tetrahydro-N-(4-methoxyphenyl)-1-Naphthalenamine vendor Eli Lilly and Roche have been riding high this week on the controversial approval of Biogen’s anti-amyloid Alzheimer’s disease drug Aduhelm (aducanumab), as its new low bar could help these Big Pharmas jump the finish line. 1,2,3,4-tetrahydro-N-(4-methoxyphenyl)-1-Naphthalenamine factory An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant.